Long-term, Low-Dose Methimazole Reduces Hyperthyroidism Relapses Long-term, Low-Dose Methimazole Reduces Hyperthyroidism Relapses

Patients with Graves ' disease randomized to a median of 8 years of treatment with methimazole showed a significantly reduced risk of relapse compared with shorter-term treatment.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news